Skip to main content
Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
3.430
-0.042 (-1.21%)
Apr 28, 2026, 5:35 PM CET

Cellectis Revenue

In the year 2025, Cellectis had annual revenue of $79.59M USD with 61.72% growth. Cellectis had revenue of $12.21M in the quarter ending December 31, 2025, a decrease of -19.51%.

Revenue
$79.59M
Revenue Growth
+61.72%
P/S Ratio
3.67
Revenue / Employee
$347.57K
Employees
229
Market Cap
248.99M EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Transgene 7.21M
Sensorion 5.81M
Valneva SE 174.66M
Genfit 65.43M
ABIONYX Pharma 4.10M
Innate Pharma 9.01M
MaaT Pharma 4.52M
Adocia 3.85M
Revenue Rankings

Cellectis News

More News